FDA Dedicating 30% Of Leftover User Fees To White Oak Move
Executive Summary
FDA has reserved nearly 30% of its unused user fees for fiscal year 2004 for the agency's upcoming move to a new facility in White Oak, Md., the FY 2004 Prescription Drug User Fee Financial Report states
You may also be interested in...
FDA May Support Incentives For Electronic Submissions In Next User Fee Act
FDA is considering using incentives to promote electronic submissions in the next version of the Prescription Drug User Fee Act
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials